Get Our Free Research Email
Private Equity Research
Focused on the Orthopedics and Dental Sector
HealthpointCapital is the leading source for research on the orthopedic and dental industry's markets, major players, technologies and trends.
The research team has created an unparalleled bank of intellectual capital that reflects a thorough understanding of the industry's dynamics,
key strategies and valuation trends. Research insights and conclusions are central to HealthpointCapital's
investment decisions. More about us...
Orthopedic & Dental Industry News
Most Recent Blog Articles Complete Archive »
Aurora Spine reports financial results...Flower Orthopedics stock sale...Symmetry Surgical seperates from Symmetry Medical...FDA postpones panel on Vertiflex spacer...Aurora Spine, DePuy, THINK Surgical, SpineGuard, VEXIM receive product clearances...Hunter Medical launches elbow system, Lima Corporate Miniums, Spine product updates...IlluminOss recieves two patents...Stryker settlement...Intrinsic Therapeutics trial enrollment...Researchers develop new method to regenerate the human meniscus...BONESUPPORT and Orthocell partnership more
A team of researchers at Columbia University Medical Center describe a newly developed methodology in a paper published in Science Translational Medicine, to replace the human meniscus utilizing a personalized 3-D printed implant (scaffold) infused with human growth factors. Damaged... more
Symmetry Surgical Inc. completed its separation from Symmetry Medical Inc., which was sold to Tecomet for $450 million in cash or 1.4x LTM revenues. Symmetry Surgical will focus on the reusable general surgical instrument market and begin trading on the... more
Conventus, Medtronic, SIRAKOSS funding...Histogenics IPO...Autocam Medical, Cardinal Health, Medtronic, Zimmer M&A updates...Benvenue Medical, Interventional Spine, SuperSonic Imagine receive product clearances...BioMedical Enterprises, Signus Medizintechnik, Zyga product launches...Spineology receives patent...Bonutti Skeletal files suit against Globus Medical...Ceterix, Cytori Therapeutics, Zyga clinical updates...IMPLANET US Medical Innovations distribution agreements...Aastrom operational updates more
Medtronic announced it has received antitrust clearances from the U.S. Federal Trade Commission (FTC), European Commission (EC), Canadian Competition Bureau (CCB), Chinese Ministry of Commerce (CMC) and South Korean Fair Trade Commission (SKFTC), regarding its $43 billion pending acquisition of... more
Histogenics priced its initial public offering (IPO) of 5.9 million shares of common stock at a price of $11.00 per share, raising total proceeds of $65 million. This equates to an enterprise value of approximately $139 million. The final terms... more
We are also a member of the Medical Device Manufacturers Association (MDMA), which champions favorable regulatory and market conditions for medical device innovators.